MKI67 and neuroendocrine neoplasm: According to the 2022 WHO Classification of Neuroendocrine Tumors, the Ki-67 LI is no longer used as a formal diagnostic criterion for PitNETs, despite being recognized as a biomarker of aggressive tumor behavior (7).